Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma

Yejun Hong; Nancy Nixon; Jeffrey Q Cao; Sangjune Laurence Lee

doi:10.3389/fonc.2023.1171444

Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma

Front Oncol. 2023 Jun 7:13:1171444. doi: 10.3389/fonc.2023.1171444. eCollection 2023.

Authors

Yejun Hong¹, Nancy Nixon², Jeffrey Q Cao³, Sangjune Laurence Lee³

Affiliations

¹ Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
² Division of Medical Oncology, University of Calgary, Calgary, AB, Canada.
³ Division of Radiation Oncology, University of Calgary, Calgary, AB, Canada.

Abstract

Palliative radiotherapy for symptomatic and intact breast tumors must balance convenience, efficacy, and risk of acute toxicity. This case report presents a patient with metastatic breast cancer and an intact fungating primary tumor. She was treated with an ultrahypofractionated radiation therapy, 26 Gy in 5 consecutive daily fractions, with sequential palliative chemotherapy. This resulted in a minimal toxicity profile and significant reduction of tumor burden and symptoms.

Keywords: breast cancer; case report; palliative; radiation complications; radiotherapy; ultrahypofractionated.

Publication types

Case Reports